The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice

Hillary R. Johnson, Laura C. Gunder, Glen E. Leverson, Evie H. Carchman

Open source

DOI
10.1097/dcr.0000000000002623
Published
2023-01-04
Container
Diseases of the Colon & Rectum
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/dcr.0000000000002623,
  title = {The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice},
  author = {Hillary R. Johnson and Laura C. Gunder and Glen E. Leverson and Evie H. Carchman},
  year = {2023},
  journal = {Diseases of the Colon \& Rectum},
  doi = {10.1097/dcr.0000000000002623},
  url = {https://doi.org/10.1097/dcr.0000000000002623}
}

RIS

TY  - JOUR
TI  - The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice
AU  - Hillary R. Johnson
AU  - Laura C. Gunder
AU  - Glen E. Leverson
AU  - Evie H. Carchman
PY  - 2023
JO  - Diseases of the Colon & Rectum
DO  - 10.1097/dcr.0000000000002623
UR  - https://doi.org/10.1097/dcr.0000000000002623
ER  - 

APA

Johnson, H. R., Gunder, L. C., Leverson, G. E., & Carchman, E. H. (2023). The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice. Diseases of the Colon & Rectum. https://doi.org/10.1097/dcr.0000000000002623

Source records